Latest News and Press Releases
Want to stay updated on the latest news?
-
PharmAla files its final short form prospectus, and announces a signed term sheet with an R&D tax credit financing firm called Radium
-
PharmAla launches new web portal for MDMA prescribers and appoints a new COO
-
PharmAla completes first domestic US shipment of MDMA from its new domestic distribution center, and issues shares as debt payment.
-
TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and...
-
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and...
-
PharmAla announces completion of onboarding for its US distribution centre and resignation of its Chief Operating Officer.
-
PharmAla incorporates a new entity in Australia to take advantage of tax incentives, and appoints Dr. Evan Lewis to its clinical advisory board.
-
PharmAla delivers over 500 LaNeo MDMA capsules to Merhavim Psychiatric Hospital to be used in a clinical trial in exchange for IP rights to trial results
-
PharmAla releases Q3 financials showing increased customer deposit and SAP sales growth
-
Pharmala files short form prospectus